These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4754476)

  • 21. Verapamil in supraventricular paroxysmal tachycardia.
    Sarkari NB; Singh MM; Barthwal SP; Bagga CB; Gupta AK
    Indian Heart J; 1979; 31(5):263-8. PubMed ID: 521040
    [No Abstract]   [Full Text] [Related]  

  • 22. Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia.
    Ballo P; Bernabò D; Faraguti SA
    Eur Heart J; 2004 Aug; 25(15):1310-7. PubMed ID: 15288158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of paroxysmal cardiac arrhythmias with verapamil(Dilacoron R + Knoll)].
    Baptista ML
    Hospital (Rio J); 1971 Feb; 79(2):323-42. PubMed ID: 5316508
    [No Abstract]   [Full Text] [Related]  

  • 24. [Electrophysiological evaluation of anti-arrhythmia therapy in patients with recurrent supraventricular and ventricular tachycardia].
    Fajuri A; González R; Diáz R; Arriagada D; Corbalán R
    Rev Med Chil; 1983 Nov; 111(11):1117-22. PubMed ID: 6678454
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiac output in patients with disturbed cardiac rhythm.
    Lukomsky PE
    Cor Vasa; 1970; 12(2):97-105. PubMed ID: 5433135
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficacy of antazoline in paroxysmal tachycardia].
    De Maestri C; Rinaldi AR
    Boll Soc Med Chir Cremona; 1966; 20(1):73-82. PubMed ID: 4380332
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effectiveness and mechanism of the anti-arrhythmic action of ritmilen in patients with paroxysms of atrioventricular node reciprocal tachycardia].
    Grosu AA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):98-9. PubMed ID: 6508939
    [No Abstract]   [Full Text] [Related]  

  • 28. [Death after intravenous application of isoptin].
    Apitz J; Gaissmaier U
    Med Klin; 1971 May; 66(20):751-5. PubMed ID: 5574936
    [No Abstract]   [Full Text] [Related]  

  • 29. [Protective electrophysiological effects of somatostatin in patients with paroxysmal atrioventricular reciprocal tachycardias].
    Kanorskií SG; Osadchií OE; Skibitskií VV; Pokrovskií VM
    Patol Fiziol Eksp Ter; 2002; (2):18-9. PubMed ID: 12152423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical uses of calcium ion antagonists in arrhythmias.
    Bender F
    Clin Invest Med; 1980; 3(1-2):21-8. PubMed ID: 7009001
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of supraventricular tachycardias with verapamil (author's transl)].
    Florenzano F; Manzur F; Palma S; Thumala A
    Rev Med Chil; 1980 Oct; 108(10):903-8. PubMed ID: 7221246
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanism of termination of reentrant atrioventricular nodal paroxysmal supraventricular tachycardia by intravenous verapamil--an intracardiac electrophysiologic study.
    Shankar SJ; Sethi KK; Khalilullah M
    Indian Heart J; 1983; 35(1):8-18. PubMed ID: 6852846
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antiarrhythmic actions of disopyramide phosphate in patients with paroxysmal supraventricular tachycardia (author's transl)].
    Satoh M; Sada T; Kuan-Min S; Kira Y; Sekine I; Okabe F; Ueda A; Ito T; Matsumoto S
    Kokyu To Junkan; 1981 May; 29(5):537-44. PubMed ID: 7313358
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of verapamil on the induction and maintenance of paroxysmal supraventricular tachycardias].
    García Civera R; Sanjuán Máñez R; Morell Cabedo S; Miralles Serrano L; García-Sacristán Fernández J; Llavador Sanchís J
    Rev Esp Cardiol; 1983; 36(4):319-28. PubMed ID: 6647961
    [No Abstract]   [Full Text] [Related]  

  • 35. [Our experiences with the beta-adrenolytic preparation Isoptin Knoll A.G].
    Zeman B
    Cas Lek Cesk; 1969 Jul; 108(35):1041-3. PubMed ID: 5802087
    [No Abstract]   [Full Text] [Related]  

  • 36. [Problems of medicinal prevention of different forms of paroxysmal tachycardia and tachyarrhythmia].
    Golikov AP; Ustinova EZ
    Ter Arkh; 1976; 48(1):90-3. PubMed ID: 1265689
    [No Abstract]   [Full Text] [Related]  

  • 37. A 61-year-old man with Holmes' heart.
    Gabbarini F
    Lancet; 1999 Feb; 353(9153):646. PubMed ID: 10030339
    [No Abstract]   [Full Text] [Related]  

  • 38. [Unusual arrhythmia in the acute phase of myocardial infarct].
    Kenedi I; Gonda F
    Orv Hetil; 1970 Apr; 111(14):804-6. PubMed ID: 5438637
    [No Abstract]   [Full Text] [Related]  

  • 39. [Paroxysmal supraventricular tachycardia: mechanisms and treatment].
    Strasberg B; Pinchas A; Agmon J
    Harefuah; 1984 Mar; 106(6):272-4. PubMed ID: 6745771
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of supraventricular paroxysmal tachycardias].
    Gavrilescu S; Pop T
    Med Interna (Bucur); 1970 Dec; 22(12):1415-28. PubMed ID: 5502463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.